Effect of Emotional Freedom Technique on Perceived Pain, Situational Anxiety and Satisfaction Levels During Mammography Screening.

May 12, 2025 updated by: Sümeyye Köse, Saglik Bilimleri Universitesi

The Effect of the Emotional Freedom Technique Applied During Mammography Screening on Perceived Pain, Situational Anxiety and Satisfaction Levels

This study was planned to determine the effect of Emotional Freedom Technique on perceived pain level, situational anxietyl and satisfaction level during mammography screening.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The randomized controlled and experimental study will be conducted with 94 women who applied to the Cancer Early Diagnosis, Screening and Education Center for mammography screening. The women in the experimental group (n=47) will be applied the Emotional Freedom Technique before mammography screening and the women in the control group (n=47) will be given routine mammography screening. The Sociodemographic Information Form, Visual Analog, Situational Anxiety Inventory, blood pressure monitor, thermometer and saturation device will be used to collect the data.

Study Type

Interventional

Enrollment (Actual)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Pendik District Health Directorate Maternal Child Health and Family Planning Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Having a first mammography screening
  • Knowing how to read and write,
  • Having entered menopause (at least 1 year has passed since the last menstruation)

Exclusion Criteria:

  • Having any cognitive or hearing problems,
  • Having used painkillers before the procedure,
  • Having no chronic diseases (cardiovascular, respiratory tract),
  • Having a diagnosed mental illness (schizophrenia, bipolar disorder),
  • Having epilepsy (as it is a contraindication for EFT applications),

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Women in the control group applying for mammography screening will not receive any intervention other than routine mammography screening.
Experimental: Intervention Group
Emotional Freedom Technique will be applied to women in the intervention group applying for mammography screening 30-40 minutes before the procedure.
The researcher will apply the Emotional Freedom Technique to women in the intervention group who apply for mammography screening for 30-40 minutes before the screening.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: 20 minute
Data will be collected using the State Anxiety Inventory. The answer options collected in four classes on the State Anxiety Inventory scale are: (1) Not at all, (2) A little, (3) A lot and (4) Completely; The options on the trait anxiety scale are (1) Rarel, (2) Sometimes, (3) A lot of the time, and (4) Almost always. The higher the score obtained from the scales, the higher the person's anxiety is. The total score obtained from the scale varies between 20-80, and 20-39 indicates a mild anxiety level, 40-59 indicates a medium anxiety level, 60-79 indicates a high anxiety level, and 80 points indicates a panic anxiety level.
20 minute
Pain Level
Time Frame: 10 minute
Data will be collected using the Visual Analogue Scale. Pain can be given a score between 0 and 10 on the scale.The higher the scale score, the greater the pain.
10 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction Level
Time Frame: 10 minutes
Data will be collected using the Visual Analog Scale. Satisfaction can be given a score between 0 and 10 on the scale. The higher the scale score, the higher the satisfaction level.
10 minutes
Blood Pressure
Time Frame: 5 minutes
The data will be measured with a blood pressure monitor, and the average normal value in blood pressure measurement will be accepted as 120/80 mmHg.
5 minutes
Thermometer
Time Frame: 5 minutes
Data will be measured from the forehead with a fever measuring device and the average normal value in body temperature measurement will be accepted as 36.5-37.5.
5 minutes
Saturation
Time Frame: 5 minutes
Data will be measured from the fingertip with a saturation device and the average normal value of the measurement will be accepted as between 95-100%.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2024

Primary Completion (Actual)

February 28, 2025

Study Completion (Actual)

March 30, 2025

Study Registration Dates

First Submitted

February 27, 2024

First Submitted That Met QC Criteria

March 5, 2024

First Posted (Actual)

March 6, 2024

Study Record Updates

Last Update Posted (Actual)

May 13, 2025

Last Update Submitted That Met QC Criteria

May 12, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SumeyyeKose-E.138186

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Emotional Freedom Technique

Subscribe